SEC Filings | Connect Biopharma Holdings Ltd

Filing date	Form	Description	Filing Group	View
June 3, 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-180546.pdf 0001193125-21-180546.rtf 0001193125-21-180546.xls View HTML
May 17, 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-163959.pdf 0001193125-21-163959.rtf 0001193125-21-163959.xls View HTML
May 11, 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-157558.pdf 0001193125-21-157558.rtf 0001193125-21-157558.xls View HTML
March 29, 2021	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Other	0001104659-21-043197.pdf 0001104659-21-043197.rtf 0001104659-21-043197.xls View HTML
March 19, 2021	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	Registration Statements	0001193125-21-087643.pdf 0001193125-21-087643.rtf 0001193125-21-087643.xls View HTML
March 19, 2021	S-8	Securities offered to employees pursuant to employee benefit plans	Registration Statements	0001193125-21-087697.pdf 0001193125-21-087697.rtf 0001193125-21-087697.xls View HTML
March 18, 2021	F-1/A	This filing is a pre-effective amendment to an F-1 filing	Registration Statements	0001193125-21-084781.pdf 0001193125-21-084781.rtf 0001193125-21-084781.xls View HTML
March 18, 2021	F-1MEF	Registration of up to an additional 20% of securities for an offering filed on an F-1	Registration Statements	0001193125-21-086327.pdf 0001193125-21-086327.rtf 0001193125-21-086327.xls View HTML
March 18, 2021	EFFECT	EFFECT	Other	9999999995-21-001006.pdf 9999999995-21-001006.rtf 9999999995-21-001006.xls View HTML
March 18, 2021	EFFECT	EFFECT	Other	9999999995-21-001011.pdf 9999999995-21-001011.rtf 9999999995-21-001011.xls View HTML

Data provided by Kaleidoscope.